DARRYL SEELHORST VS. IMMUNOMEDICS, INC. (L-1226-20, MORRIS COUNTY AND STATEWIDE)

CourtNew Jersey Superior Court Appellate Division
DecidedJune 7, 2021
DocketA-0350-20
StatusUnpublished

This text of DARRYL SEELHORST VS. IMMUNOMEDICS, INC. (L-1226-20, MORRIS COUNTY AND STATEWIDE) (DARRYL SEELHORST VS. IMMUNOMEDICS, INC. (L-1226-20, MORRIS COUNTY AND STATEWIDE)) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DARRYL SEELHORST VS. IMMUNOMEDICS, INC. (L-1226-20, MORRIS COUNTY AND STATEWIDE), (N.J. Ct. App. 2021).

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-0350-20

DARRYL SEELHORST and JAMES TAWN VIGIE,

Plaintiffs-Appellants,

v.

IMMUNOMEDICS, INC., DEBRA WARNER, and WILLIAM CONKLING,

Defendants-Respondents. ___________________________

Submitted May 12, 2021 – Decided June 7, 2021

Before Judges Sumners and Geiger.

On appeal from the Superior Court of New Jersey, Law Division, Morris County, Docket No. L-1226-20.

Joseph & Kirschenbaum, LLP, attorneys for appellants (Lucas C. Buzzard, on the briefs).

Littler Mendelson, P., attorneys for respondents (Ivan R. Novich and Sandra T. Jimenez, on the brief).

PER CURIAM Plaintiffs Darryl Seelhorst and James Tawn Vigie appeal from an August

28, 2020 order granting defendants Immunomedics, Inc. (the Company), Debra

Warner, and William Conkling's motion to compel arbitration and staying this

action while plaintiffs' claims were being arbitrated. We affirm.

The facts relevant to the arbitration provisions are not in dispute. From

October 2018 until January 9, 2020, plaintiffs were employed by the Company

as oncology account managers or pharmaceutical sales representatives. As a

term and condition of their employment, plaintiffs were required to agree to and

execute the Company's "Arbitration Policy With Respect To Dispute Resolution

and Arbitration" (the Arbitration Agreement). Plaintiffs certified that they "read

and understood, and agree[d] to comply with, [the Arbitration Agreement]."

In relevant part, the Arbitration Agreement provides:

The Company will try and resolve disputes with employees through internal discussions. However, if disputes cannot be resolved, you may submit your claim to the American Arbitration Association ("AAA") for final and binding arbitration under the AAA's Employment Dispute Rules. The Company may also submit any claim it has against you to arbitration. Copies of the AAA’s current Rules are available from the Company’s Human Resources Department.

1) This Arbitration Procedure covers all claims or controversies arising out of your employment or its termination ("Claims"). It covers Claims concerning discipline and discharge, benefits, job

A-0350-20 2 bidding, seniority rights, safety rules, and the interpretation or application of any of the provisions of the Company's Employee Handbook. It covers Claims for wages or other compensation or benefits; Claims for breach of any contract or covenant whether express or implied; tort Claims; Claims for discrimination (including, but not limited to, race, color, sex, sexual orientation or preference, religion, national origin, age, marital status, handicap or disability, veteran or citizenship status); Claims of sexual harassment; and Claims for violation of any federal, state, or local government constitution, law, statute, regulation, or ordinance.

....

3) A written arbitration demand must be made no later than ninety (90) calendar days after the Claim arises, unless a longer period is otherwise provided by law, or it will be conclusively resolved against the claiming party.

7) The arbitrator shall issue a written award and an opinion explaining the award. The arbitrator's decision shall be final, binding, and subject to review only pursuant to the Federal Arbitration Act or comparable state law.

9) This Arbitration Procedure bars litigation in any court by either the Company or you of any Claim that should be arbitrated under the Procedure. However, you and the Company have

A-0350-20 3 the right to move in court to compel arbitration or to confirm and enforce an arbitrator's award under this Arbitration Procedure.

In the event that any court determines for any reason that this Arbitration Procedure is not binding, or otherwise allows any litigation regarding a Claim covered by this Arbitration Procedure to go forward, the Company and you agree that (i) the court proceeding must be commenced no later than six (6) months after the court makes such a determination, unless a longer period is otherwise provided by law; and (ii) all rights to a trial by jury in the litigation are expressly waived.

[(Emphasis added).]

On January 9, 2020, the Company terminated plaintiffs' employment.

Five months later, plaintiffs filed a two-count complaint alleging: (1)

defendants retaliated and wrongfully discharged them for complaining about

allegedly unlawful Company practices, in violation of the Conscientious

Employee Protection Act (CEPA), N.J.S.A. 34:19-1 to -14 (count one); and (2)

the Company fraudulently induced plaintiffs to enter into employment

agreements and continue their employment with the Company by

misrepresenting the state of its business, its ability to meet sales targets, and

plaintiffs' compensation (count two).

In lieu of filing an answer, defendants moved to compel arbitration in

accordance with the Arbitration Agreement and to dismiss count two as time-

A-0350-20 4 barred under a provision of the Arbitration Agreement. The Company argued

that plaintiffs entered into the Arbitration Agreement and their claims were

encompassed by its broad provisions, which specifically included CEPA claims.

The Company asserted that "no magic words are required" to create an

enforceable agreement to arbitrate employee disputes and claims. Relying on

the "strong public policy in favor of arbitration[,]" the Company stated that

"reasonable doubts . . . should be resolved in favor of arbitration." The Company

contended that the use of the word "may" did not make the Arbitration

Agreement permissive, because such an interpretation is "inconsistent with the

other language in the agreement . . . ."

Plaintiffs opposed the motion, contending the Arbitration Agreement

Policy gave each party a permissive right to elect arbitration but did not mandate

arbitration of plaintiffs' claims as the exclusive means of dispute resolution and

that count two was not time-barred. Plaintiffs argued that the operative language

of the Arbitration Agreement was permissive, stating that if disputes with

employees could not be resolved "through internal discussions" employees "may

submit [their] claim to the [AAA] for final and binding arbitration under the

AAA's Employment Dispute Rules." Plaintiffs contended that because the

Arbitration Agreement did not state that "the employee must submit his claim

A-0350-20 5 to arbitration," they did not clearly and unambiguously waive their right to

litigate their claims in court. They further argued that the operative language

was conditional and ambiguous and that any ambiguity in the Arbitration

Agreement should resolved against the Company, which drafted it.

On August 28, 2020, the court issued an order and written statement of

reasons granting defendants' motion to compel arbitration and staying the action

while plaintiffs' claims were being arbitrated. The court rejected plaintiffs'

argument that arbitration is not compulsory, stating:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Michael E. Hirsch v. Amper Financial Services, LLC (070751)
71 A.3d 849 (Supreme Court of New Jersey, 2013)
Martindale v. Sandvik, Inc.
800 A.2d 872 (Supreme Court of New Jersey, 2002)
Sonitrol Holding Co. v. Marceau Investissements
607 A.2d 1177 (Supreme Court of Delaware, 1992)
Garfinkel v. Morristown Obstetrics & Gynecology Associates, P.A.
773 A.2d 665 (Supreme Court of New Jersey, 2001)
Kieffer v. Best Buy
14 A.3d 737 (Supreme Court of New Jersey, 2011)
Patricia Atalese v. U.S. Legal Services Group, L.P. (072314)
99 A.3d 306 (Supreme Court of New Jersey, 2014)
Annemarie Morgan v. Sanford Brown Institute(075074)
137 A.3d 1168 (Supreme Court of New Jersey, 2016)
Young v. Prudential Insurance Co. of America, Inc.
688 A.2d 1069 (New Jersey Superior Court App Division, 1997)
NAACP of Camden County East v. Foulke Management Corp.
24 A.3d 777 (New Jersey Superior Court App Division, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
DARRYL SEELHORST VS. IMMUNOMEDICS, INC. (L-1226-20, MORRIS COUNTY AND STATEWIDE), Counsel Stack Legal Research, https://law.counselstack.com/opinion/darryl-seelhorst-vs-immunomedics-inc-l-1226-20-morris-county-and-njsuperctappdiv-2021.